Rate control in the medical management of atrial fibrillation.
作者信息
Camm A J, Savelieva I, Lip G Y H
机构信息
Division of Cardiac & Vascular Sciences, St George's University of London, London, UK.
出版信息
Heart. 2007 Jan;93(1):35-8. doi: 10.1136/hrt.2006.099903. Epub 2006 Sep 4.
Abstract
摘要
相似文献
1
Rate control in the medical management of atrial fibrillation.心房颤动医学管理中的心率控制
Heart. 2007 Jan;93(1):35-8. doi: 10.1136/hrt.2006.099903. Epub 2006 Sep 4.
2
Electrical and pharmacologic cardioversion for atrial fibrillation.心房颤动的电复律和药物复律
Med Clin North Am. 2008 Jan;92(1):101-20, xi. doi: 10.1016/j.mcna.2007.08.003.
3
4
Electrical and pharmacologic cardioversion for atrial fibrillation.心房颤动的电复律和药物复律
Cardiol Clin. 2009 Feb;27(1):95-107, ix. doi: 10.1016/j.ccl.2008.09.008.
5
Atrial fibrillation and acute decompensated heart failure.心房颤动与急性失代偿性心力衰竭
Circ Heart Fail. 2009 Jan;2(1):72-3. doi: 10.1161/CIRCHEARTFAILURE.108.830349.
6
Choosing a treatment strategy for atrial fibrillation.选择心房颤动的治疗策略。
Harv Heart Lett. 2001 May;11(9):1-4.
7
[Guidelines for the management of patients with atrial fibrillation. Executive summary].[心房颤动患者管理指南。执行摘要]
Rev Esp Cardiol. 2006 Dec;59(12):1329.
8
[Restoration of the sinus rhythm in atrial fibrillation].[心房颤动时窦性心律的恢复]
Can J Cardiol. 1996 Feb;12 Suppl A:27A-34A.
9
Atrial fibrillation: rate versus rhythm control.心房颤动：心率控制与节律控制
J Ark Med Soc. 2005 Oct;102(4):110-2.
10
The substrate maintaining persistent atrial fibrillation.维持持续性心房颤动的底物。
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):2-5. doi: 10.1161/CIRCEP.108.764233.
引用本文的文献
1
Efficacy and Safety of Combined Catheter Ablation and Left Atrial Appendage Closure in Atrial Fibrillation: A Systematic Review and Meta-Analysis.导管消融联合左心耳封堵治疗心房颤动的疗效与安全性：一项系统评价和Meta分析
Cureus. 2025 Apr 23;17(4):e82817. doi: 10.7759/cureus.82817. eCollection 2025 Apr.
2
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201).多中心、2 期、埃替班特鼻喷雾剂治疗有症状的心房颤动患者快速心室率急性降低的疗效和安全性的随机对照研究（ReVeRA-201）。
Circ Arrhythm Electrophysiol. 2023 Dec;16(12):639-650. doi: 10.1161/CIRCEP.123.012567. Epub 2023 Nov 11.
3
Towards Improved Human Models for Cardiac Arrhythmia: Disease Mechanisms, Treatment, and Models of Atrial Fibrillation.迈向改进的心律失常人体模型：疾病机制、治疗及心房颤动模型
Biomedicines. 2023 Aug 23;11(9):2355. doi: 10.3390/biomedicines11092355.
4
Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.地尔硫䓬与直接口服抗凝剂联合使用与心房颤动患者出血风险之间的关联。
J Interv Card Electrophysiol. 2023 Apr;66(3):629-635. doi: 10.1007/s10840-022-01355-1. Epub 2022 Sep 23.
5
Perception of atrial fibrillation symptoms: Impact on quality of life and treatment in older adults.心房颤动症状的感知：对老年人生活质量和治疗的影响。
J Am Geriatr Soc. 2022 Oct;70(10):2805-2817. doi: 10.1111/jgs.17954. Epub 2022 Jul 6.
6
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition.心房颤动诱发的心动过速性心肌病与心力衰竭：一种未得到充分认识且难以捉摸的病症。
Heart Fail Rev. 2022 Nov;27(6):2119-2135. doi: 10.1007/s10741-022-10221-1. Epub 2022 Mar 23.
7
Associations Between Clinical Outcomes and a Recently Proposed Adult Congenital Heart Disease Anatomic and Physiological Classification System.临床结局与最近提出的成人先天性心脏病解剖和生理分类系统之间的关联。
J Am Heart Assoc. 2021 Sep 21;10(18):e021345. doi: 10.1161/JAHA.120.021345. Epub 2021 Sep 6.
8
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.心力衰竭合并心房颤动患者的β受体阻滞剂治疗：挑战与展望。
J Geriatr Cardiol. 2021 May 28;18(5):362-375. doi: 10.11909/j.issn.1671-5411.2021.05.008.
9
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.口服抗凝剂与维拉帕米或地尔硫卓与肾功能正常的非瓣膜性心房颤动患者不良出血事件的关联。
JAMA Netw Open. 2020 Apr 1;3(4):e203593. doi: 10.1001/jamanetworkopen.2020.3593.
10
Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.75 岁及以上心房颤动患者共病与心血管终点事件及治疗效果的关系。
Am J Med. 2020 Oct;133(10):e554-e567. doi: 10.1016/j.amjmed.2020.03.038. Epub 2020 Apr 19.
本文引用的文献
1
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.持续性房颤合并轻至中度心力衰竭患者的心率控制与节律控制：心率控制与电复律（RACE）研究结果
Am Heart J. 2005 Jun;149(6):1106-11. doi: 10.1016/j.ahj.2004.11.030.
2
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.β受体阻滞剂长期治疗慢性心力衰竭患者时房颤的预后相关性：COMET研究结果
Eur Heart J. 2005 Jul;26(13):1303-8. doi: 10.1093/eurheartj/ehi166. Epub 2005 Mar 14.
3
Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.心房颤动患者的生活质量：节律管理心房颤动随访调查（AFFIRM）研究
Am Heart J. 2005 Jan;149(1):112-20. doi: 10.1016/j.ahj.2004.03.065.
4
Cost-effectiveness of rhythm versus rate control in atrial fibrillation.心房颤动中节律控制与心率控制的成本效益
Ann Intern Med. 2004 Nov 2;141(9):653-61. doi: 10.7326/0003-4819-141-9-200411020-00005.
5
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?在心房颤动合并充血性心力衰竭患者中，节律控制是否优于心率控制？
Am J Cardiol. 2004 Sep 15;94(6):797-800. doi: 10.1016/j.amjcard.2004.06.009.
6
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.对于持续性房颤患者，心率控制比节律控制更具成本效益——来自心率控制与电复律（RACE）研究的结果。
Eur Heart J. 2004 Sep;25(17):1542-9. doi: 10.1016/j.ehj.2004.06.020.
7
Control of heart rate versus rhythm in rheumatic atrial fibrillation: a randomized study.风湿性心房颤动中心率与节律的控制：一项随机研究。
J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):65-73. doi: 10.1177/107424840400900201.
8
Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.非瓣膜性持续性心房颤动患者的心率控制与节律控制：波兰如何治疗慢性心房颤动（HOT CAFE）研究结果
Chest. 2004 Aug;126(2):476-86. doi: 10.1378/chest.126.2.476.
9
Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).房颤患者心率达标与预后的关系（来自节律控制房颤随访研究[AFFIRM]）
Am J Cardiol. 2004 May 15;93(10):1247-53. doi: 10.1016/j.amjcard.2004.01.069.
10
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.心房颤动节律管理后续调查（AFFIRM）研究：心房颤动的心率控制方法
J Am Coll Cardiol. 2004 Apr 7;43(7):1201-8. doi: 10.1016/j.jacc.2003.11.032.
Zotero 插件